Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: Cross-over Study on the Influence of Fampridine on Working Memory in Mild to Moderate Depression [Phase 2]

View source ↗

Summary

This Phase 2 cross-over trial investigates whether dalfampridine affects working memory in people with mild to moderate depression and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dalfampridine (dalfampridine)

Snippet

Sponsor: University of Basel | Conditions: Working Memory, Mild to Moderate Depression | Phase 2 | Status: RECRUITING